Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 30% ± 11% | |
ciliated cell | 3 studies | 22% ± 5% |
Insufficient scRNA-seq data for expression of CDK7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 821.67 | 21 / 21 | 100% | 35.74 | 504 / 504 |
breast | 100% | 945.31 | 459 / 459 | 100% | 45.12 | 1118 / 1118 |
esophagus | 100% | 1268.46 | 1445 / 1445 | 100% | 28.04 | 183 / 183 |
ovary | 100% | 729.99 | 180 / 180 | 100% | 28.37 | 430 / 430 |
prostate | 100% | 914.89 | 245 / 245 | 100% | 34.11 | 502 / 502 |
uterus | 100% | 828.39 | 170 / 170 | 100% | 36.22 | 459 / 459 |
thymus | 100% | 927.21 | 653 / 653 | 100% | 39.65 | 604 / 605 |
stomach | 100% | 686.68 | 359 / 359 | 100% | 32.39 | 285 / 286 |
adrenal gland | 100% | 1238.49 | 258 / 258 | 100% | 29.36 | 229 / 230 |
kidney | 100% | 1042.91 | 89 / 89 | 100% | 31.30 | 897 / 901 |
intestine | 100% | 818.54 | 966 / 966 | 99% | 37.27 | 524 / 527 |
lung | 99% | 874.17 | 573 / 578 | 100% | 31.83 | 1155 / 1155 |
brain | 99% | 712.74 | 2608 / 2642 | 100% | 20.67 | 705 / 705 |
liver | 100% | 459.55 | 225 / 226 | 98% | 19.53 | 399 / 406 |
pancreas | 98% | 518.84 | 321 / 328 | 99% | 28.72 | 177 / 178 |
skin | 100% | 1649.01 | 1809 / 1809 | 97% | 26.04 | 458 / 472 |
adipose | 100% | 878.98 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 31.36 | 29 / 29 |
spleen | 100% | 800.32 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 34.24 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.30 | 1 / 1 |
muscle | 100% | 1026.35 | 800 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 836.49 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 467.67 | 810 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 18.22 | 75 / 80 |
peripheral blood | 79% | 720.07 | 732 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0006281 | Biological process | DNA repair |
GO_2000045 | Biological process | regulation of G1/S transition of mitotic cell cycle |
GO_0042795 | Biological process | snRNA transcription by RNA polymerase II |
GO_0051301 | Biological process | cell division |
GO_0050821 | Biological process | protein stabilization |
GO_0006367 | Biological process | transcription initiation at RNA polymerase II promoter |
GO_0006468 | Biological process | protein phosphorylation |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0070985 | Cellular component | transcription factor TFIIK complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000439 | Cellular component | transcription factor TFIIH core complex |
GO_0001650 | Cellular component | fibrillar center |
GO_0070516 | Cellular component | CAK-ERCC2 complex |
GO_0000307 | Cellular component | cyclin-dependent protein kinase holoenzyme complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0001673 | Cellular component | male germ cell nucleus |
GO_0005675 | Cellular component | transcription factor TFIIH holo complex |
GO_0005634 | Cellular component | nucleus |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0004672 | Molecular function | protein kinase activity |
GO_0008353 | Molecular function | RNA polymerase II CTD heptapeptide repeat kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0008094 | Molecular function | ATP-dependent activity, acting on DNA |
GO_0005515 | Molecular function | protein binding |
GO_0004693 | Molecular function | cyclin-dependent protein serine/threonine kinase activity |
Gene name | CDK7 |
Protein name | Cyclin-dependent kinase 7 [RNA-polymerase]-subunit kinase (EC 2.7.11.23) Cyclin-dependent kinase 7 (EC 2.7.11.23) (Cell division protein kinase 7) Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) |
Synonyms | MO15 STK1 hCG_1988840 CAK1 CDKN7 CAK |
Description | FUNCTION: Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminal domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts . Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53; this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition. . |
Accessions | D6RGG9 P50613 ENST00000502604.5 ENST00000613505.4 ENST00000622424.4 ENST00000626796.2 D6RAD4 ENST00000629350.2 ENST00000618909.4 ENST00000614881.4 ENST00000510106.5 D6REC6 ENST00000615854.4 ENST00000615305.4 D6RF14 ENST00000514676.5 ENST00000515391.5 D6RI01 ENST00000628367.2 D6R9G1 ENST00000506789.5 ENST00000256443.8 ENST00000617941.4 ENST00000506563.5 D6RIG9 D6R9Z2 ENST00000504147.5 ENST00000515180.5 ENST00000617026.4 A0A0S2Z3F9 ENST00000508726.5 ENST00000614858.4 ENST00000629972.2 D6RFL0 ENST00000617289.4 |